<DOC>
	<DOC>NCT02558088</DOC>
	<brief_summary>The objective of the study is to help establish a urinary threshold for salmeterol on the World Anti-doping Agency prohibited list, to avoid supratherapeutic of this substance in competitive sports. Hence, there is no hypothesis as such.</brief_summary>
	<brief_title>Pharmacological Properties of Salmeterol</brief_title>
	<detailed_description />
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Male 1845 years Healthy Chronic disease Smoking Habitual use of medicine Allergy towards salmeterol Unable to exercise on a bike ergometer</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>salmeterol</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>doping</keyword>
	<keyword>beta2-agonists</keyword>
	<keyword>long-acting beta2-agonists</keyword>
</DOC>